CBD CELL BY DESIGN
DEAD

Serial Number

79272557

Owner

Quality by Design, naamloze vennootschap

Filing Date

Sep 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CBD CELL BY DESIGN Trademark

Serial Number: 79272557

CBD CELL BY DESIGN is a trademark filed by Quality by Design, naamloze vennootschap on September 11, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Quality by Design, naamloze vennootschap

Fotografielaan 5

Entity Type: 32

Antleron, naamloze vennootschap

Ambachtenlaan 1

Entity Type: 32

Trademark Details

Filing Date

September 11, 2019

Registration Date

Not Registered

Goods & Services

Computer software; cloud computing software; computer software platforms; data buses; data processing software; data mining software; computer software to enable the searching of data; computer-aided measuring software; models for scientific experiments; process development platform software; artificial intelligence and machine learning software; sensory software; biosensors; bioreactors for cell culturing; bioreactors for research use; cell culture software for laboratory and medical use; incubators for cell culture

Medical and veterinary preparations and articles; pharmaceutical preparations; diagnostic preparations and materials; live organs and tissues for surgical purpose; tissue-regenerative pharmaceutical preparations; pharmaceutical implants; biological implants; biological preparations for medical and veterinary purposes; biological tissue cultures for medical and veterinary purposes; stem cells; stem cells for medical and veterinary purposes; implants for guided tissue regeneration; biological implants comprised of living tissue or grown from stem cells for surgical purposes; stem cells for regenerative clinical, medical or pharmaceutical use

Scientific and technological services; research services; industrial analysis services; scientific research and development; scientific research and analysis; product research and development; analytical laboratory services; laboratory research, analysis and testing; scientific laboratory services; biomedical research services; research and development in the pharmaceutical and biotechnology fields; research and development in the field of therapeutics; biomedical research and screening; scientific services relating to the isolation and cultivation of human tissues and cells; engineering services; medical engineering; design services; design and development of medical devices; design and development of cell production processes; design and development of implants, human tissue and cells; scientific and technical data analysis; preparation of scientific reports; conducting of technical feasibility studies; testing and evaluation services; development of measuring, testing and analysis methods; research and development of new measuring and testing technology for others; material testing and analysis; product safety testing; scientific screening for cell culture; computer-aided measuring and non-destructive testing in the biomedical field; development of process systems for the biotechnology and biomedical industry; cloud computing services; platform as a service; software as a service; development of cloud-based process platforms; advice, consultancy and information relating to the aforesaid, included in this class

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 13, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 13, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 10, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 21, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 21, 2021 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 13, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 13, 2021 ABN2
REFUSAL PROCESSED BY IB
Oct 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 30, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2020 DOCK
ASSIGNED TO EXAMINER
Aug 23, 2020 DOCK
ASSIGNED TO EXAMINER
Dec 8, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 30, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 21, 2019 REPR